1
Atomoxetine and DAW2022 on OSA Severity
Condition(s):Obstructive Sleep ApneaLast Updated:May 2, 2022Not yet recruiting
Atomoxetine: 204 Clinical Trials, Page 1 of 21
Hide Studies Not Open or Pending
2
Bariatric Surgery and Pharmacokinetics of Atomoxetine
Condition(s):Obesity, MorbidLast Updated:March 22, 2022Recruiting
3
Safety Study to Assess Atomoxetine With MA Abusers and Healthy Controls
Condition(s):Continuous Methamphetamine Dependence; Methamphetamine Dependence in RemissionLast Updated:May 12, 2016Completed
4
Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine
Condition(s):Alcohol Use DisorderLast Updated:May 6, 2022Recruiting
5
Post-stroke Neural Plasticity With Atomoxetine
Condition(s):Atomoxetine Hydrochloride; PlacebosLast Updated:August 14, 2017Completed
6
Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)
Condition(s):Memory Disorders; Multiple SclerosisLast Updated:March 13, 2020Completed
7
Effects of Atomoxetine in Mild Cognitive Impairment
Condition(s):Mild Cognitive ImpairmentLast Updated:July 23, 2019Completed
8
Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH
Condition(s):Neurogenic Orthostatic HypotensionLast Updated:April 5, 2019Completed
9
Atomoxetine in Veterans With Comorbid ADHD/PTSD
Condition(s):Post Traumatic Stress Disorder; Attention Deficit Hyperactivity DisorderLast Updated:April 3, 2019Completed
10
Atomoxetine in Patients With Tourette’s Syndrome
Condition(s):Tourette SyndromeLast Updated:January 29, 2021Not yet recruiting